EGFR and non-small cell lung carcinoma: Activating epidermal growth factor receptor (EGFR) mutations exon 19 deletions (ex19del) and exon 21 L858R mutations make up 85%–90% of non-small cell lung cancer (NSCLC) cases (Gazdar, 2009).